Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,256.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 12.00 (0.963%)
Market Cap: £575.57m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

AGM Statement

25 Sep 2025 07:00

RNS Number : 7169A
Cohort PLC
25 September 2025
 

One Waterside Drive

Arlington Business Park

Reading

Berks

RG7 4SW

 

 

 

25 September 2025

 

 

 

 

 

 

COHORT PLC

("Cohort" or "the Group")

 

AGM UPDATE ANNOUNCEMENT

 

Cohort, the AIM listed independent technology group, is today holding its Annual General Meeting (AGM) and issues the following comments on current trading and outlook.

 

Cohort achieved record financial results in the year ended 30 April 2025 ("FY2025"), with strong performances in revenue, adjusted operating profit, order intake, adjusted EPS, and net funds. The year ended with a cash position that exceeded expectations and a record order book of £616.4m, extending out to the mid-2030s, with strong revenue cover for the current financial year ending 30 April 2026 ("FY2026").

 

Our expectations for growth in FY2026 remain unchanged, with a weighting to the second half as in previous years. Trading performance in the first half is expected to be slightly behind the strong comparative period last year. In the first quarter's trading, a strong maiden contribution from EM Solutions was offset by a reduction in MCL's activity, which was at a record level last year, and a weaker mix at both ELAC and SEA including the sale of the latter's transport business in May 2025.

 

Following contract wins since the start of FY2026 of over £60m, the order book on 20 September 2025 stood at over £590m, representing consensus FY2026 revenue cover of nearly 90%.

 

We are optimistic about our prospects for further significant new orders, given demand for our products and services from both domestic and export customers.

 

As previously disclosed in the FY2025 Final Results announcement, given planned capital expenditure including the completion of ELAC SONAR's new facility in Kiel in the first half and the unwinding of the strong year end working capital position, primarily customer advances, we expect the Group to report net debt in the region of £30m at the half year. We expect to close FY2026 with net funds in the range of £10m to £15m as previously reported.

 

The Group's strategy continues to be to grow both organically and through acquisitions. The Group's acquisition of EM Solutions for an enterprise value of £75m completed on 31 January 2025, and we have seen a positive contribution in the first four months of FY2026. Geopolitical tensions are driving increased investment in defence, as highlighted by the UK Strategic Defence Review in June, and those are expected to persist, creating the conditions for organic growth. Our business model is also well adapted to generating value from carefully targeted acquisitions, and we continue to seek opportunities for these in the UK and elsewhere.

 

The interim results for the six months ending 31 October 2025 are due to be released in December 2025.

 

ENDS

 

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

Simon Walther, Finance Director

Raquel McGrath, Company Secretary

Kellie Young, Group Head of Investor Communications and Events

Investec Bank Plc (Financial Adviser, Nominated Adviser, and Corporate Broker)

020 7597 5970

Carlton Nelson, Christopher Baird, Charlotte Young

MHP

07817 458804

Reg Hoare, Ollie Hoare, Hugo Harris

cohort@mhpgroup.com

 

 

NOTES TO EDITORS

 

Cohort plc (www.cohortplc.com) is the parent company of seven innovative, agile and responsive businesses based in the UK, Australia, Germany and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has headquarters in Reading, Berkshire and employs in total over 1,500 core staff there and at its other operating company sites across the UK, Australia Germany, and Portugal.

 

The group is split into two segments - Communications and Intelligence, and Sensors and Effectors:

 

Communications and Intelligence

 

· EID designs and manufactures advanced communications systems for naval and military customers. Cohort acquired a majority stake in June 2016. www.eid.pt

· EM Solutions designs, assembles, tests, and supports satellite communications on-the-move terminals for defence and government customers. It also provides high-end broadband radio transceivers and other RF Subsystems such as low noise receivers and solid-state high-power transmitters for defence and commercial customers. Acquired by Cohort in January 2025. www.emsolutions.com.au 

· MASS is a specialist data technology company serving the defence and security markets, focused on electronic warfare, digital services, and training support. Acquired by Cohort in August 2006. www.mass.co.uk

· MCL designs, sources, and supports advanced electronic and surveillance technology for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

 

Sensors and Effectors

 

· Chess Dynamics offers surveillance, tracking and fire-control systems to the defence and security markets. Chess has been part of the Group since December 2018. www.chess-dynamics.com

· ELAC SONAR supplies advanced sonar systems and underwater communications to global customers in the naval marketplace. Acquired by Cohort in December 2020. www.elac-sonar.de 

· SEA delivers and supports technology-based products for the defence and transport markets alongside specialist research and training services. Acquired by Cohort in October 2007. www.sea.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEAFULEISEFU
Date   Source Headline
16th Sep 20245:34 pmRNSHolding(s) in Company
2nd Sep 20245:08 pmRNSTotal Voting Rights
2nd Sep 202411:32 amRNSHolding(s) in Company
27th Aug 20245:54 pmRNSBlock listing six monthly return
21st Aug 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Aug 20243:48 pmRNSDirector/PDMR Shareholding
16th Aug 202412:10 pmRNSHolding(s) in Company
12th Aug 20244:22 pmRNSDirector/PDMR Shareholding
2nd Aug 20242:30 pmRNSDirector/PDMR Shareholding
1st Aug 202411:43 amRNSTotal Voting Rights
29th Jul 20249:45 amRNSDirector/PDMR Shareholding
23rd Jul 20245:04 pmRNSDirector/PDMR Shareholding
17th Jul 20247:01 amRNSContract win
17th Jul 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSContract Award
11th Jul 20247:00 amRNSNotice of Results
1st Jul 20249:33 amRNSTotal Voting Rights
5th Jun 202410:59 amRNSEBT Purchase of Shares
31st May 20243:17 pmRNSTotal Voting Rights
23rd May 20241:30 pmRNSEBT Purchase of Shares
23rd May 20247:00 amRNSFull Year Trading Update
20th May 20244:01 pmRNSEBT Purchase of Shares
14th May 20242:10 pmRNSEBT Purchase of Shares
7th May 20245:24 pmRNSEBT Purchase of Shares
3rd May 202411:44 amRNSDirector/PDMR Shareholding
1st May 20245:17 pmRNSDirector/PDMR Shareholding
1st May 20245:11 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSBlock Listing Application
30th Apr 20247:00 amRNSSite visit to SEA
15th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20242:19 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:19 pmRNSBlock Listing Six Monthly Return
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 20242:06 pmRNSHolding(s) in Company
27th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSContract Win
19th Mar 20249:43 amRNSContract win
13th Mar 202410:49 amRNSDirector/PDMR Shareholding
1st Mar 20247:00 amRNSTotal Voting Rights
26th Feb 20244:28 pmRNSBlock listing six monthly return
16th Feb 202412:38 pmRNSDirector/PDMR Shareholding
1st Feb 202410:02 amRNSTotal Voting Rights
29th Jan 20247:00 amRNSContract Win
17th Jan 20243:25 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSInterim Report 2023
2nd Jan 202412:05 pmRNSTotal Voting Rights
22nd Dec 202312:07 pmRNSHolding(s) in Company
13th Dec 20237:01 amRNSDirectorate Change
13th Dec 20237:00 amRNSHalf Year Results
7th Dec 20237:00 amRNSEquity Development Presentation on 13 December

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.